These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
135 related articles for article (PubMed ID: 26503996)
1. Can Imatinib Be Safely Withdrawn in Patients with Surgically Resected Metastatic GIST? Hompland I; Bruland ØS Anticancer Res; 2015 Nov; 35(11):5759-65. PubMed ID: 26503996 [TBL] [Abstract][Full Text] [Related]
2. Preoperative imatinib treatment in patients with advanced gastrointestinal stromal tumors: patient experiences and systematic review of 563 patients. Xu J; Ling TL; Wang M; Zhao WY; Cao H Int Surg; 2015 May; 100(5):860-9. PubMed ID: 26011207 [TBL] [Abstract][Full Text] [Related]
4. Preoperative imatinib mesylate (IM) for huge gastrointestinal stromal tumors (GIST). Tang S; Yin Y; Shen C; Chen J; Yin X; Zhang B; Yao Y; Yang J; Chen Z World J Surg Oncol; 2017 Apr; 15(1):79. PubMed ID: 28399894 [TBL] [Abstract][Full Text] [Related]
5. A safety evaluation of imatinib mesylate in the treatment of gastrointestinal stromal tumor. Ben Ami E; Demetri GD Expert Opin Drug Saf; 2016; 15(4):571-8. PubMed ID: 26865352 [TBL] [Abstract][Full Text] [Related]
6. Surgical Treatment of Gastrointestinal Stromal Tumors Located in the Stomach in the Imatinib Era. Stiekema J; Kol S; Cats A; Yazdi AT; van Coevorden F; van Sandick JW Am J Clin Oncol; 2015 Oct; 38(5):502-7. PubMed ID: 24064754 [TBL] [Abstract][Full Text] [Related]
7. Is 3-years duration of adjuvant imatinib mesylate treatment sufficient for patients with high-risk gastrointestinal stromal tumor? A study based on long-term follow-up. Lin JX; Chen QF; Zheng CH; Li P; Xie JW; Wang JB; Lu J; Chen QY; Cao LL; Lin M; Tu RH; Huang CM J Cancer Res Clin Oncol; 2017 Apr; 143(4):727-734. PubMed ID: 28083710 [TBL] [Abstract][Full Text] [Related]
9. [Lancet in the era of targeted drug therapy: the role of surgery in the management of advanced gastrointestinal stromal tumor]. Cao H; Wang M Zhonghua Wei Chang Wai Ke Za Zhi; 2016 Nov; 19(11):1211-1216. PubMed ID: 27928787 [TBL] [Abstract][Full Text] [Related]
10. The economic burden of gastrointestinal stromal tumor (GIST) recurrence in patients who have received adjuvant imatinib therapy. Guerin A; Sasane M; Gauthier G; Keir CH; Zhdavana M; Wu EQ J Med Econ; 2015 Mar; 18(3):241-8. PubMed ID: 25422992 [TBL] [Abstract][Full Text] [Related]
11. Long-term follow-up of patients with GIST undergoing metastasectomy in the era of imatinib -- analysis of prognostic factors (EORTC-STBSG collaborative study). Bauer S; Rutkowski P; Hohenberger P; Miceli R; Fumagalli E; Siedlecki JA; Nguyen BP; Kerst M; Fiore M; Nyckowski P; Hoiczyk M; Cats A; Casali PG; Treckmann J; van Coevorden F; Gronchi A Eur J Surg Oncol; 2014 Apr; 40(4):412-9. PubMed ID: 24491288 [TBL] [Abstract][Full Text] [Related]
12. Outcome of metastatic GIST in the era before tyrosine kinase inhibitors. Gold JS; van der Zwan SM; Gönen M; Maki RG; Singer S; Brennan MF; Antonescu CR; De Matteo RP Ann Surg Oncol; 2007 Jan; 14(1):134-42. PubMed ID: 17080234 [TBL] [Abstract][Full Text] [Related]
13. Indications for surgery in advanced/metastatic GIST. Ford SJ; Gronchi A Eur J Cancer; 2016 Aug; 63():154-67. PubMed ID: 27318456 [TBL] [Abstract][Full Text] [Related]
14. [A Case of Local Resection for Rectal GIST Following Neoadjuvant Imatinib Mesylate Treatment]. Yoshioka Y; Tokoro T; Ushijima H; Daito K; Kawamura J; Ueda K; Hida J; Okuno K Gan To Kagaku Ryoho; 2017 Nov; 44(12):1997-1999. PubMed ID: 29394846 [TBL] [Abstract][Full Text] [Related]
15. Surgery of residual disease following molecular-targeted therapy with imatinib mesylate in advanced/metastatic GIST. Gronchi A; Fiore M; Miselli F; Lagonigro MS; Coco P; Messina A; Pilotti S; Casali PG Ann Surg; 2007 Mar; 245(3):341-6. PubMed ID: 17435538 [TBL] [Abstract][Full Text] [Related]
16. [Treatment of patients with gastrointestinal stromal tumour with imatinib mesylate]. Haugland HK; Jebsen NL; Mannelqvist M; Skar R; Eide J; Øvrebø K; Horn A; Jensen DK; Monge OR; Lilleng PK Tidsskr Nor Laegeforen; 2005 Apr; 125(7):868-72. PubMed ID: 15815732 [TBL] [Abstract][Full Text] [Related]
17. The Story of Imatinib in GIST - a Journey through the Development of a Targeted Therapy. Reichardt P Oncol Res Treat; 2018; 41(7-8):472-477. PubMed ID: 29895025 [TBL] [Abstract][Full Text] [Related]
18. [Medical therapy of GIST; from palliative to curative treatment]. Le Cesne A; Blay JY Bull Acad Natl Med; 2012; 196(4-5):861-74; discussion 874-76. PubMed ID: 23550449 [TBL] [Abstract][Full Text] [Related]